etomoxir has been researched along with Uterine Cervical Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ba, G; Chu, BB; Du, QJ; Han, J; Han, YQ; Li, J; Lu, WF; Ming, SL; Sun, MM; Wang, J; Wu, HT; Yang, GY; Zeng, L | 1 |
1 other study(ies) available for etomoxir and Uterine Cervical Neoplasms
Article | Year |
---|---|
Myostatin knockout induces apoptosis in human cervical cancer cells via elevated reactive oxygen species generation.
Topics: A549 Cells; Animals; Antioxidants; Apoptosis; Cachexia; Caspases; Cell Line, Tumor; Cell Proliferation; Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR-Cas Systems; Cytochromes c; Epoxy Compounds; Fatty Acids; Female; Gene Knockout Techniques; HEK293 Cells; HeLa Cells; Humans; Lipid Metabolism; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Myostatin; Oxidation-Reduction; Reactive Oxygen Species; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2018 |